These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12095647)

  • 21. Characterization of the 5-hydroxytryptamine receptors mediating contraction in the intestine of Suncus murinus.
    Javid FA; Naylor RJ
    Br J Pharmacol; 1999 Aug; 127(8):1867-75. PubMed ID: 10482918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Slowing of intestinal transit by fat depends on an ondansetron - sensitive, efferent serotonergic pathway.
    Lin HC; Chen JH
    Neurogastroenterol Motil; 2003 Jun; 15(3):317-22. PubMed ID: 12787341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of putative carcinoid mediators on gastric and small bowel transit in rats and the role of 5-HT receptors.
    Valdovinos MA; Thomforde GM; Camilleri M
    Aliment Pharmacol Ther; 1993 Feb; 7(1):61-6. PubMed ID: 7679934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine (5-HT)-induced depolarization in isolated abdominal vagus nerves in the rat: involvement of 5-HT3 and 5-HT4 receptors.
    Nemoto M; Endo T; Minami M; Yoshioka M; Ito H; Saito H
    Res Commun Mol Pathol Pharmacol; 2001; 109(3-4):217-30. PubMed ID: 11758651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Actions of 5-hydroxytryptophan to inhibit and disinhibit mouse behaviour in the light/dark test.
    Cheng CH; Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1994 Apr; 255(1-3):39-49. PubMed ID: 7913044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological properties of a novel gastrointestinal prokinetic benzamide selective for human 5-HT4 receptor versus human 5-HT3 receptor.
    Nagakura Y; Akuzawa S; Miyata K; Kamato T; Suzuki T; Ito H; Yamaguchi T
    Pharmacol Res; 1999 May; 39(5):375-82. PubMed ID: 10328995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Possible involvement of 5-HT and 5-HT2 receptors in acceleration of gastrointestinal transit by escin Ib in mice.
    Matsuda H; Li Y; Yoshikawa M
    Life Sci; 2000; 66(23):2233-8. PubMed ID: 10855943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of various 5-HT3 receptor antagonists, granisetron, ondansetron, ramosetron and azasetron on serotonin (5-HT) release from the ferret isolated ileum.
    Endo T; Minami M; Kitamura N; Teramoto Y; Ogawa T; Nemoto M; Hamaue N; Hirafuji M; Yasuda E; Blower PR
    Res Commun Mol Pathol Pharmacol; 1999; 104(2):145-55. PubMed ID: 10634307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence for a 5-HT3 receptor involvement in the facilitation of peristalsis on mucosal application of 5-HT in the guinea pig isolated ileum.
    Tuladhar BR; Kaisar M; Naylor RJ
    Br J Pharmacol; 1997 Nov; 122(6):1174-8. PubMed ID: 9401783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wood creosote prevents CRF-induced motility via 5-HT3 receptors in proximal and 5-HT4 receptors in distal colon in rats.
    Ataka K; Kuge T; Fujino K; Takahashi T; Fujimiya M
    Auton Neurosci; 2007 May; 133(2):136-45. PubMed ID: 17182287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased defaecation caused by 5-HT4 receptor activation in the mouse.
    Banner SE; Smith MI; Bywater D; Gaster LM; Sanger GJ
    Eur J Pharmacol; 1996 Jul; 308(2):181-6. PubMed ID: 8840130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5-HT4 receptor antagonism in irritable bowel syndrome: effect of SB-207266-A on rectal sensitivity and small bowel transit.
    Houghton LA; Jackson NA; Whorwell PJ; Cooper SM
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1437-44. PubMed ID: 10571599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RS 39604: a potent, selective and orally active 5-HT4 receptor antagonist.
    Hegde SS; Bonhaus DW; Johnson LG; Leung E; Clark RD; Eglen RM
    Br J Pharmacol; 1995 Jul; 115(6):1087-95. PubMed ID: 7582507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
    Moskwa A; Boznańska P
    Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of 5-HT4 and 5-HT7 receptor expression and function in the circular muscle of the human colon.
    Irving HR; Tan YY; Tochon-Danguy N; Liu H; Chetty N; Desmond PV; Pouton CW; Coupar IM
    Life Sci; 2007 Mar; 80(13):1198-205. PubMed ID: 17258778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5-HT3 receptor antagonists. 3. Quinoline derivatives which may be effective in the therapy of irritable bowel syndrome.
    Kishibayashi N; Miwa Y; Hayashi H; Ishii A; Ichikawa S; Nonaka H; Yokoyama T; Suzuki F
    J Med Chem; 1993 Oct; 36(22):3286-92. PubMed ID: 8230119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Which type of 5-hydroxytryptamine receptor mediates relaxation of the longitudinal muscle of guinea pig proximal colon in vitro?
    Sevcík J; Ruzicka V; Slánsky J; Masek K
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):421-30. PubMed ID: 8900213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Serotonin (5-HT)3 receptors: antagonists and their pharmacological profiles].
    Miyata K; Honda K
    Nihon Yakurigaku Zasshi; 1994 Sep; 104(3):143-52. PubMed ID: 7959407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.